| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Vitor H Pomin | Q89287076 |
| P2093 | author name string | Barbara Mulloy | |
| Ariana A Vasconcelos | |||
| William P Vignovich | |||
| Alysia V Gonzales | |||
| P2860 | cites work | Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair | Q21284516 |
| FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation | Q24317993 | ||
| Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta | Q24321274 | ||
| Contaminated heparin associated with adverse clinical events and activation of the contact system | Q24619723 | ||
| Targeting selectins and selectin ligands in inflammation and cancer | Q24658204 | ||
| Holothurian fucosylated chondroitin sulfate | Q27015773 | ||
| The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria | Q27650818 | ||
| Dermatan sulfate: new functions from an old glycosaminoglycan | Q28221133 | ||
| Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin | Q28378937 | ||
| 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) | Q28565680 | ||
| A chondroitin sulfate proteoglycan PTPzeta /RPTPbeta regulates the morphogenesis of Purkinje cell dendrites in the developing cerebellum | Q28584222 | ||
| Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues | Q33312192 | ||
| Marine sulfated glycans with serpin-unrelated anticoagulant properties | Q33358325 | ||
| Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin | Q33384050 | ||
| Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications. | Q33393960 | ||
| Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients | Q33400253 | ||
| Chondroitin sulfate proteoglycans regulate the growth, differentiation and migration of multipotent neural precursor cells through the integrin signaling pathway | Q33511675 | ||
| Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells | Q33564244 | ||
| Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion. | Q33622909 | ||
| Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of | Q72626713 | ||
| Preparation and structural determination of dermatan sulfate-derived oligosaccharides | Q73075426 | ||
| Structure of fucose branches in the glycosaminoglycan from the body wall of the sea cucumber Stichopus japonicus | Q73131482 | ||
| Depolymerized holothurian glycosaminoglycan (DHG) prevents neointimal formation in balloon-injured rat carotid artery | Q73153527 | ||
| A novel pentasaccharide sequence GlcA(3-sulfate)(beta1-3)GalNAc(4-sulfate)(beta1-4)(Fuc alpha1-3)GlcA(beta1-3)GalNAc(4-sulfate) in the oligosaccharides isolated from king crab cartilage chondroitin sulfate K and its differential susceptibility to ch | Q73202291 | ||
| The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs | Q73553860 | ||
| Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences | Q73586120 | ||
| Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist | Q74272184 | ||
| Neuronal cell adhesion, mediated by the heparin-binding neuroregulatory factor midkine, is specifically inhibited by chondroitin sulfate E. Structural ans functional implications of the over-sulfated chondroitin sulfate | Q74291012 | ||
| Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro | Q74586215 | ||
| Antithrombotic activity of a fucosylated chondroitin sulphate from echinoderm: sulphated fucose branches on the polysaccharide account for its antithrombotic action | Q74800874 | ||
| Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4 | Q77353640 | ||
| Fucosylated chondroitin sulfate as a new oral antithrombotic agent | Q79397768 | ||
| Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment | Q79984417 | ||
| Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart | Q81277934 | ||
| Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease | Q81297178 | ||
| Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan | Q81443643 | ||
| Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury | Q81746823 | ||
| Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate | Q81920488 | ||
| Contaminated heparin preparations, severe adverse events and the contact system | Q82059532 | ||
| Keratan sulfate restricts neural plasticity after spinal cord injury | Q82665689 | ||
| Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides | Q83949098 | ||
| Residual keratan sulfate in chondroitin sulfate formulations for oral administration | Q84641715 | ||
| CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia | Q85598285 | ||
| Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase | Q86455056 | ||
| Structure and biological activity of a fucosylated chondroitin sulfate from the sea cucumber Cucumaria japonica | Q86935245 | ||
| Plasma contact activation by a fucosylated chondroitin sulfate and its structure-activity relationship study | Q90281980 | ||
| Fucosylated chondroitin sulfates from the sea cucumbers Holothuria tubulosa and Holothuria stellati | Q91274576 | ||
| Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate | Q47419242 | ||
| Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability | Q47860795 | ||
| Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins | Q47958114 | ||
| Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells | Q48124371 | ||
| Separation, purification, structures and anticoagulant activities of fucosylated chondroitin sulfates from Holothuria scabra | Q49646347 | ||
| Specificity of glycosaminoglycan-protein interactions | Q49894342 | ||
| 2,3-Di-O-sulfo glucuronic acid: An unmodified and unusual residue in a highly sulfated chondroitin sulfate from Litopenaeus vannamei. | Q49903394 | ||
| Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding | Q50106129 | ||
| Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications. | Q50297103 | ||
| Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease. | Q50436943 | ||
| Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation. | Q51032187 | ||
| A highly regular fucosylated chondroitin sulfate from the sea cucumber Massinium magnum: Structure and effects on coagulation. | Q51040318 | ||
| Sulfation pattern of fucose branches affects the anti-hyperlipidemic activities of fucosylated chondroitin sulfate. | Q51332075 | ||
| Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis. | Q51745450 | ||
| A characteristic chondroitin sulfate trisaccharide unit with a sulfated fucose branch exhibits neurite outgrowth-promoting activity: Novel biological roles of fucosylated chondroitin sulfates isolated from the sea cucumber Apostichopus japonicus. | Q52097113 | ||
| Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans. | Q39374452 | ||
| From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods | Q39387837 | ||
| The role of human natural killer-1 (HNK-1) carbohydrate in neuronal plasticity and disease | Q39435938 | ||
| Structural characterization of fucosylated chondroitin sulfates from sea cucumbers Apostichopus japonicus and Actinopyga mauritiana. | Q39453677 | ||
| Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. | Q39524033 | ||
| Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Plac | Q39539742 | ||
| Heparin crisis 2008: a tipping point for increased FDA enforcement in the pharma sector? | Q39913740 | ||
| Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism | Q40284089 | ||
| Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein | Q40348272 | ||
| Dermatan sulfate as a potential therapeutic agent | Q40550054 | ||
| Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration | Q40619052 | ||
| Dermatan sulfate binds and potentiates activity of keratinocyte growth factor (FGF-7). | Q40705979 | ||
| Distinct structures of the α-fucose branches in fucosylated chondroitin sulfates do not affect their anticoagulant activity. | Q40818091 | ||
| Medical Gains of Chondroitin Sulfate Upon Fucosylation | Q40912959 | ||
| The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth | Q41465984 | ||
| Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598). The role of glycosaminoglycans present on the luminal cell surface | Q41467314 | ||
| Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium | Q41683514 | ||
| Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor | Q41687540 | ||
| Chondroitinase ABC digestion of dermatan sulphate. N.m.r. spectroscopic characterization of the oligo- and poly-saccharides | Q42008547 | ||
| Identification of keratan sulfate disaccharide at C-3 position of glucuronate of chondroitin sulfate from Mactra chinensis | Q42155645 | ||
| Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage | Q42251572 | ||
| The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics | Q42366909 | ||
| Cerebral Hemorrhage Complicating Heparin-induced Thrombocytopenia after Percutaneous Coronary Intervention: A Clinical Dilemma of Medical Treatment | Q42538047 | ||
| Novel sulfated oligosaccharides containing 3-O-sulfated glucuronic acid from king crab cartilage chondroitin sulfate K. Unexpected degradation by chondroitinase ABC. | Q42643132 | ||
| Characteristic hexasaccharide sequences in octasaccharides derived from shark cartilage chondroitin sulfate D with a neurite outgrowth promoting activity. | Q42671875 | ||
| Evolution of glycosaminoglycans: Comparative biochemical study. | Q42741712 | ||
| 1H-n.m.r. investigation of naturally occurring and chemically oversulphated dermatan sulphates. Identification of minor monosaccharide residues | Q42794083 | ||
| Fucosylated chondroitin sulfate attenuates renal fibrosis in animals submitted to unilateral ureteral obstruction: a P-selectin-mediated event? | Q42879490 | ||
| N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. | Q43081631 | ||
| Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm | Q43588777 | ||
| Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities | Q43617920 | ||
| Fucosylated chondroitin sulfate from Acaudina molpadioides improves hyperglycemia via activation of PKB/GLUT4 signaling in skeletal muscle of insulin resistant mice | Q43636050 | ||
| Structure of a fucose-branched chondroitin sulfate from sea cucumber. Evidence for the presence of 3-O-sulfo-beta-D-glucuronosyl residues | Q43663568 | ||
| Detection of keratan sulfate by immunological methods in commercial chondroitin sulfate preparations | Q43700679 | ||
| Characterization of currently marketed heparin products: adverse event relevant bioassays | Q43717471 | ||
| Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates. | Q43922680 | ||
| Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury | Q44002381 | ||
| Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues | Q44131360 | ||
| A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis. | Q44259046 | ||
| Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model | Q44358780 | ||
| Fractions of chemically oversulphated galactosaminoglycan sulphates inhibit three enveloped viruses: human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus | Q44466925 | ||
| Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro | Q44545061 | ||
| Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro | Q44552011 | ||
| Modulation of native chondroitin sulphate structure in tissue development and in disease | Q44706510 | ||
| Two fucosylated chondroitin sulfates from the sea cucumber Eupentacta fraudatrix | Q46400237 | ||
| Characterization and anticoagulant activity of a fucosylated chondroitin sulfate with unusually procoagulant effect from sea cucumber | Q46962901 | ||
| Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size | Q47194797 | ||
| A novel structural fucosylated chondroitin sulfate from Holothuria Mexicana and its effects on growth factors binding and anticoagulation | Q47238270 | ||
| Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease | Q47370006 | ||
| Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studies | Q47377923 | ||
| Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics | Q47379826 | ||
| The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination | Q33679221 | ||
| Understanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library Screening | Q33690582 | ||
| Chondroitin Sulfate-Rich Extract of Skate Cartilage Attenuates Lipopolysaccharide-Induced Liver Damage in Mice. | Q33833408 | ||
| Characterization of glycosaminoglycans by 15N NMR spectroscopy and in vivo isotopic labeling | Q33909062 | ||
| Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates | Q33911458 | ||
| Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells | Q33999637 | ||
| Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways | Q34003880 | ||
| Biosynthesis of chondroitin/dermatan sulfate | Q34168651 | ||
| Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate | Q34271235 | ||
| Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity | Q34317336 | ||
| Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex | Q34321775 | ||
| Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice | Q34341743 | ||
| The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure | Q34403775 | ||
| Glycomics Hits the Big Time | Q34432774 | ||
| Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. | Q34475404 | ||
| The dermatan sulfate proteoglycan decorin modulates α2β1 integrin and the vimentin intermediate filament system during collagen synthesis | Q34506615 | ||
| Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells | Q34598936 | ||
| Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates. | Q34605048 | ||
| Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events | Q34774203 | ||
| The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy | Q35208842 | ||
| The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy | Q35239936 | ||
| Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells | Q35558089 | ||
| Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands | Q35685184 | ||
| Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate | Q35743476 | ||
| Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. | Q35844016 | ||
| Discovery of an intrinsic tenase complex inhibitor: Pure nonasaccharide from fucosylated glycosaminoglycan | Q35845738 | ||
| Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma | Q35894756 | ||
| Sugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds | Q35947477 | ||
| Chondroitin sulfate proteoglycans in neural development and regeneration. | Q36049261 | ||
| Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. | Q36059429 | ||
| Lessons learned from the contamination of heparin | Q36399734 | ||
| Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib | Q36475626 | ||
| Therapeutic value of glycosaminoglycans in cancer | Q36598106 | ||
| Intracerebral hemorrhage in stroke patients anticoagulated with heparin | Q38718635 | ||
| Dual and antagonic therapeutic effects of sulfated glycans | Q38835664 | ||
| Chondroitin sulphate: a focus on osteoarthritis | Q38838064 | ||
| The structure of a fucosylated chondroitin sulfate from the sea cucumber Cucumaria frondosa | Q38864137 | ||
| Occurrence of sulfated fucose branches in fucosylated chondroitin sulfate are essential for the polysaccharide effect preventing muscle damage induced by toxins and crude venom from Bothrops jararacussu snake | Q39036740 | ||
| Chondroitin sulfate (CS) lyases: Structure, function and application in therapeutics | Q39066124 | ||
| The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry | Q39107593 | ||
| Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope | Q39139323 | ||
| Distribution of sulfated mucopolysaccharides in invertebrates | Q39140533 | ||
| Functional chondroitin sulfate from Enteroctopus dofleini containing a 3-O-sulfo glucuronic acid residue. | Q52148586 | ||
| Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. | Q52510803 | ||
| Two structurally similar fucosylated chondroitin sulfates from the holothurian species Stichopus chloronotus and Stichopus horrens. | Q52630214 | ||
| The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system. | Q52679512 | ||
| Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. | Q53226588 | ||
| Biosynthesis of the escherichia coli K4 capsule polysaccharide. A parallel system for studies of glycosyltransferases in chondroitin formation. | Q54571908 | ||
| Glycosaminoglycans and Proteoglycans. | Q54995051 | ||
| Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation. | Q55656164 | ||
| Highly Sulfated Dermatan Sulfates from Ascidians | Q57268109 | ||
| Quantitation of Dermatan Sulfate Active Site for Heparin Cofactor II by 1H Nuclear Magnetic Resonance Spectroscopy | Q57563867 | ||
| Presentation of IFN- to Nitric Oxide-Producing Cells: A Novel Function for Mast Cells | Q58377548 | ||
| Structure and Anti-Inflammatory Activity of a New Unusual Fucosylated Chondroitin Sulfate from | Q58546545 | ||
| Harnessing chondroitin sulphate in composite scaffolds to direct progenitor and stem cell function for tissue repair | Q58824761 | ||
| Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm | Q63944705 | ||
| Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials | Q64137153 | ||
| Chondroitin Sulfate Safety and Quality | Q64253125 | ||
| Glucose branches in chondroitin sulfates from squid cartilage | Q67586611 | ||
| Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis | Q68166937 | ||
| Primary mesenchyme cell migration requires a chondroitin sulfate/dermatan sulfate proteoglycan | Q68190079 | ||
| A new dermatan polysulfate, chondroitin sulfate H, from hagfish notochord | Q68473135 | ||
| A novel dermatan polysulfate from hagfish skin, containing trisulfated disaccharide residues | Q68490809 | ||
| Structural differences of dermatan sulfates from different origins | Q69485403 | ||
| The haemorrhagic and antithrombotic effects of dermatan sulphate | Q69658587 | ||
| Heparin induced bleeding | Q70376772 | ||
| Occurrence of a unique fucose-branched chondroitin sulfate in the body wall of a sea cucumber | Q70411706 | ||
| Activation of heparin cofactor II by heparin and dermatan sulfate | Q70815256 | ||
| A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity | Q70825897 | ||
| Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action | Q71514914 | ||
| Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate | Q71606321 | ||
| Determination of the HNK-1 epitope (3-sulphated glucuronic acid) in intact chondroitin sulphates by ELISA. Application to squid skin proteoglycans and their oversulphated carbohydrate structures | Q71633824 | ||
| High affinity of a fucosylated chondroitin sulfate for plasma low density lipoprotein | Q71746465 | ||
| Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins | Q72202483 | ||
| Acidic polysaccharides of the ascidian Styela plicata. Biosynthetic studies on the sulfated L-galactans of the tunic, and preliminary characterization of a dermatan sulfate-like polymer in body tissues | Q72371605 | ||
| Emergence and structural characteristics of chondroitin sulfates in the animal kingdom | Q36713846 | ||
| Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors | Q36713851 | ||
| Comparison of physicochemical characteristics and anticoagulant activities of polysaccharides from three sea cucumbers | Q36806702 | ||
| Chondroitin/dermatan sulfate in the central nervous system | Q36967533 | ||
| Chondroitin sulfate, hyaluronic acid and chitin/chitosan production using marine waste sources: characteristics, applications and eco-friendly processes: a review. | Q36994144 | ||
| Sulfation of the bikunin chondroitin sulfate chain determines heavy chain·hyaluronan complex formation | Q37095368 | ||
| Inhibitors of selectin functions in the treatment of inflammatory skin disorders. | Q37116804 | ||
| Potential effects of chondroitin sulfate on joint swelling: a GAIT report | Q37167150 | ||
| The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents | Q37210375 | ||
| Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease | Q37228522 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q37230656 | ||
| Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | Q37310621 | ||
| Potential therapeutic application of chondroitin sulfate/dermatan sulfate | Q37347125 | ||
| Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite | Q37373064 | ||
| Quality of different chondroitin sulfate preparations in relation to their therapeutic activity | Q37611121 | ||
| Modulation of inflammation by chondroitin sulfate | Q37732933 | ||
| Vascular Dermatan Sulfate and Heparin Cofactor II | Q37784316 | ||
| Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule | Q37951364 | ||
| Glycosaminoglycans: key players in cancer cell biology and treatment | Q37983930 | ||
| Case study: contamination of heparin with oversulfated chondroitin sulfate | Q38008265 | ||
| Anticoagulant motifs of marine sulfated glycans | Q38212639 | ||
| Fucosylated chondroitin sulfate diversity in sea cucumbers: a review | Q38240498 | ||
| Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines | Q38292486 | ||
| Isolation and structural determination of novel sulfated hexasaccharides from squid cartilage chondroitin sulfate E that exhibits neuroregulatory activities | Q38295796 | ||
| The binding of chondroitin sulfate to pleiotrophin/heparin-binding growth-associated molecule is regulated by chain length and oversulfated structures | Q38317418 | ||
| Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells | Q38323484 | ||
| Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity | Q38338617 | ||
| Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans. | Q38339525 | ||
| Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II. | Q38350746 | ||
| Heterogeneity of the chondroitin sulfate portion of phosphacan/6B4 proteoglycan regulates its binding affinity for pleiotrophin/heparin binding growth-associated molecule. | Q38352991 | ||
| Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. | Q38371965 | ||
| Antimicrobial Sulfated Glycans: Structure and Function | Q38516688 | ||
| A Dilemma in the Glycosaminoglycan-Based Therapy: Synthetic or Naturally Unique Molecules? | Q38543731 | ||
| Autoimmune heparin-induced thrombocytopenia | Q38605630 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 15 | |
| P921 | main subject | arthralgia | Q683498 |
| P577 | publication date | 2019-08-01 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Galactosaminoglycans: Medical Applications and Drawbacks | |
| P478 | volume | 24 |
| Q99634964 | Aggrecan, the Primary Weight-Bearing Cartilage Proteoglycan, Has Context-Dependent, Cell-Directive Properties in Embryonic Development and Neurogenesis: Aggrecan Glycan Side Chain Modifications Convey Interactive Biodiversity | cites work | P2860 |
Search more.